Cite
Variant-genetic and transcript-expression analysis showed a role for the chemokine-receptor CCR5 in COVID-19 severity
MLA
Helena Gil-Peña, et al. “Variant-Genetic and Transcript-Expression Analysis Showed a Role for the Chemokine-Receptor CCR5 in COVID-19 Severity.” International Immunopharmacology, vol. 98, Sept. 2021, p. 107825. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....13eaadf6e3dd902791b6e7660154f257&authtype=sso&custid=ns315887.
APA
Helena Gil-Peña, Francisco J. Jimeno-Demuth, Elena Domínguez-Garrido, Sergio Pérez-Oliveira, Victoria Alvarez, Marta García-Clemente, Inés López-Alonso, Guillermo M. Albaiceta, José Gutiérrez-Rodríguez, Cristina Hernández-González, Juan Gómez, Ana I. Enriquez, Beatriz Suarez-Alvarez, Carlos López-Larrea, Tamara Hermida, Elías Cuesta-Llavona, Salvador Tranche, Laura Amado-Rodríguez, & Eliecer Coto. (2021). Variant-genetic and transcript-expression analysis showed a role for the chemokine-receptor CCR5 in COVID-19 severity. International Immunopharmacology, 98, 107825.
Chicago
Helena Gil-Peña, Francisco J. Jimeno-Demuth, Elena Domínguez-Garrido, Sergio Pérez-Oliveira, Victoria Alvarez, Marta García-Clemente, Inés López-Alonso, et al. 2021. “Variant-Genetic and Transcript-Expression Analysis Showed a Role for the Chemokine-Receptor CCR5 in COVID-19 Severity.” International Immunopharmacology 98 (September): 107825. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....13eaadf6e3dd902791b6e7660154f257&authtype=sso&custid=ns315887.